Researchers suggest that specialized nutritional rehabilitation programs and cachexia clinics are ideal for managing anorexia-cachexia syndrome in patients with cancer.

Cancer cachexia impacts almost 90% of people living with pancreatic cancer. Learn more about this condition in this Q&A with Nicolas Clifford, PanCAN’s manager of research and education communication.

The metabolism–cancer axis is currently at a critical inflection point. A landmark August 2025 JAMA Oncology study reported a 17% reduction in overall ...

The Pancreatic Cancer Action Network is holding a webinar “Nutrition and Pancreatic Cancer: Weight Loss, Enzymes and More” to talk about common nutritional challenges related to pancreatic cancer.

A breakthrough AI system is revolutionizing cancer immunotherapy by enabling scientists to design protein-based keys that train a patient s immune cells to attack cancer with extreme precision. This ...

Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients, well above the standard of care benchmark from GnP of 35% overall survival; On track for expanded pancreatic cancer ...

MARCH 4, 2026, NEW YORK - Ludwig Cancer Research is proud to announce that Director of the Oxford Branch of the Ludwig Institute for Cancer Research ...

The team is led by Leanne Li of The Francis Crick Institute in London, England. Her research combines cancer biology and neuroscience to investigate how cancer communicates with peripheral nerves ...

Ludwig Cancer Research is proud to announce that Director of the Oxford Branch of the Ludwig Institute for Cancer Research Xin Lu and the Institute’s CEO and Scientific Director Chi Van Dang are ...

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells more effectively. Their strategy targets a hidden “off switch” that tumors ...

EXCLUSIVE: Bestselling Essex Serpent author Sarah Perry has written about dying in one of the most remarkable books of the ...

Detailed price information for Artelo Biosciences Inc (ARTL-Q) from The Globe and Mail including charting and trades.